trending Market Intelligence /marketintelligence/en/news-insights/trending/dg9io6wd3imqtrblegxgia2 content esgSubNav
In This List

Eleven Biotherapeutics changes name to Sesen Bio

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Eleven Biotherapeutics changes name to Sesen Bio

Eleven Biotherapeutics Inc. is changing its name to Sesen Bio Inc.

The company's shares will start trading under the new name and Nasdaq ticker symbol SESN, effective May 17.

Eleven Biotherapeutics is a biologic oncology company that focuses on the design and development of targeted protein therapeutics addressing areas of unmet medical needs in cancer.